News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Alvotech and Teva’s U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea, Accepted
Wednesday, February 19, 2025Alvotech a global biotech company focused on developing and manufacturing biosimilar medicines and Teva Pharmaceuticals have announced that the US Food and Drug Administration FDA has accepted a Biologics License Application
Cellistic introduces Allo Chassis™: Ready-to-use immune-shielded iPSC cell lines for affordable cell therapy development
Tuesday, February 18, 2025Cellistic a specialist in iPSCbased offtheshelf cell therapy development and manufacturing has introduced Allo Chassisreadytouse immuneshielded iPSC cell lines derived from CD and CD Tcell primary cells
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
Friday, February 14, 2025Evolus Inc a performance beauty company with a focus on building an aesthetic portfolio today announced that the US Food and Drug Administration FDA has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Friday, February 14, 2025Conduit Pharmaceuticals Inc is pleased to announce an agreement with Charles River Laboratories Inc Charles River to evaluate AZD and its derivatives in a clinically relevant Systemic Lupus Erythematosus model This collaboration highlights
Illuccix® Approved in the United Kingdom
Thursday, February 13, 2025Telix Pharmaceuticals Limited announces that the United Kingdom UK Medicines and Healthcare Products Regulatory Agency MHRA has approved the Marketing Authorization Application MAA for its prostate cancer PET imaging agent Illuccix
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
Thursday, February 13, 2025BioCryst Pharmaceuticals Inc announced that Infarmed in Portugal has recommended ORLADEYO berotralstat for the routine prevention of recurrent attacks of hereditary angioedema HAE in eligible patients years and older With this recommendation HAE pat...
Alloy Therapeutics partners with Pfizer in a long-term collaboration to develop a new antibody discovery platform.
Wednesday, February 12, 2025Alloy Therapeutics a biotechnology company focused on making advanced drug discovery technologies more accessible has announced a new partnership with Pfizer The collaboration aims to develop a platform that will improve Pfizers ability to identify e...
SpringWorks Therapeutics receives FDA approval for GOMEKLI™ (mirdametinib) to treat adults and children with NF1-PN.
Wednesday, February 12, 2025SpringWorks Therapeutics has received FDA approval for GOMEKLI mirdametinib a MEK inhibitor to treat adults and children aged two years and older with neurofibromatosis type NF who have symptomatic plexiform neurofibromas PN that cannot be fully rem...
Novartis to expand late-stage cardiovascular portfolio with USD 925 million acquisition of Anthos Therapeutics
Tuesday, February 11, 2025Novartis has signed an agreement to acquire Anthos Therapeutics a Bostonbased clinicalstage biopharmaceutical company Anthos Therapeutics is developing abelacimab a latestage treatment aimed at preventing stroke and systemic embolism in patients with...
Immix Biopharma gains FDA Regenerative Medicine Advanced Therapy designation for NXC-201, an optimised CAR-T treatment for relapsed or refractory AL amyloidosis
Tuesday, February 11, 2025Immix Biopharma a clinicalstage biopharmaceutical company focused on cell therapies for AL amyloidosis and immunemediated diseases has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for N...
